Obesity
|
disease |
Pathological Conditions, Signs and Symptoms; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
2821
|
1111
|
0.690 |
limited |
1.000 |
9 |
2
|
2001 |
2020 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.400 |
None |
1.000 |
17 |
|
2006 |
2019 |
Steatohepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
1143
|
75
|
0.360 |
None |
0.857 |
7 |
|
2012 |
2020 |
Fatty Liver
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
875
|
35
|
0.330 |
None |
0.750 |
4 |
|
2016 |
2020 |
Drug-Induced Liver Disease
|
phenotype |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
537
|
29
|
0.310 |
None |
1.000 |
2 |
|
2018 |
2018 |
Diabetes Mellitus
|
group |
Nutritional and Metabolic Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
2803
|
824
|
0.300 |
None |
0.917 |
12 |
1
|
2001 |
2017 |
Lipoidosis
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
44
|
|
0.300 |
None |
1.000 |
3 |
|
2005 |
2007 |
Hepatitis, Toxic
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Injury or Poisoning
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chemically-Induced Liver Toxicity
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
412
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Cognition Disorders
|
group |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
607
|
47
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Hepatitis, Drug-Induced
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
418
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Drug-Induced Acute Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
413
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Liver Cirrhosis, Experimental
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Experimental Model of Disease
|
870
|
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Complications of Diabetes Mellitus
|
group |
Endocrine System Diseases
|
Disease or Syndrome
|
240
|
35
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Chemical and Drug Induced Liver Injury
|
disease |
Digestive System Diseases; Chemically-Induced Disorders
|
Disease or Syndrome
|
461
|
38
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Intrahepatic Cholestasis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
54
|
3
|
0.200 |
None |
1.000 |
1 |
|
2008 |
2008 |
Acute alcoholic liver disease
|
disease |
Digestive System Diseases; Chemically-Induced Disorders; Mental Disorders
|
Disease or Syndrome
|
35
|
|
0.200 |
None |
1.000 |
1 |
|
2017 |
2017 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
29 |
|
2003 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
0.941 |
17 |
|
2002 |
2019 |
Diabetes
|
disease |
Endocrine System Diseases
|
Disease or Syndrome
|
2359
|
710
|
0.100 |
None |
0.900 |
10 |
1
|
2001 |
2015 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.100 |
None |
0.900 |
10 |
|
2011 |
2019 |
Decreased resting energy expenditure
|
phenotype |
|
Finding
|
12
|
|
0.100 |
None |
|
0 |
|
|
|
OBESITY, MILD, EARLY-ONSET
|
phenotype |
|
Finding
|
2
|
2
|
0.100 |
None |
|
0 |
2
|
|
|
Increased waist to hip ratio
|
phenotype |
|
Finding
|
11
|
|
0.100 |
None |
|
0 |
|
|
|
Myeloid Leukemia, Chronic
|
disease |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1172
|
115
|
0.090 |
None |
0.889 |
9 |
|
2007 |
2018 |